NZ332712A - Polypeptide inhibitors of protein farnesyl transferase - Google Patents
Polypeptide inhibitors of protein farnesyl transferaseInfo
- Publication number
- NZ332712A NZ332712A NZ332712A NZ33271297A NZ332712A NZ 332712 A NZ332712 A NZ 332712A NZ 332712 A NZ332712 A NZ 332712A NZ 33271297 A NZ33271297 A NZ 33271297A NZ 332712 A NZ332712 A NZ 332712A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- optionally substituted
- farnesyl transferase
- protein farnesyl
- heteroarylalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Inhibitors of protein farnesyl transferase enzymes of formula (I), wherein R1, R2, R4 & R21 are independently selected from hydrogen and alkyl, RQ is a 4-alkyleneimidazole group optionally substituted with an alkyl group on either nitrogen atom, A is -CORa, -CONHRa, -CSRa, -C(O)SRa, -C(S)ORa, -C(S)NHRa, -SO2Ra, -CONRa2 or -C(S)NRa2, wherein each Ra is independently selected from alkyl, cycloalkylalkyl, arylalkyl and heteroarylalkyl, R3 is selected from alkyl and optionally substituted cycloalkylalkyl, arylalkyl and heteroarylalkyl and R5 is an optionally substituted C2-C3 alkylene (optionally containing an oxygen atom) terminated with one or two aryl or heteroaryl groups. The compounds are useful in treating cancer, restenosis, psoriasis, endometriosis, atherosclerosis, or viral infections.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1611096P | 1996-05-22 | 1996-05-22 | |
US3366296P | 1996-12-17 | 1996-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ332712A true NZ332712A (en) | 2000-07-28 |
Family
ID=26688183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ332712A NZ332712A (en) | 1996-05-22 | 1997-04-29 | Polypeptide inhibitors of protein farnesyl transferase |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0938494A1 (en) |
JP (1) | JP2000511527A (en) |
CN (1) | CN1219174A (en) |
AU (1) | AU728477B2 (en) |
BG (1) | BG102936A (en) |
BR (1) | BR9709354A (en) |
CA (1) | CA2253934A1 (en) |
CO (1) | CO4960642A1 (en) |
CZ (1) | CZ376498A3 (en) |
EA (1) | EA199801031A1 (en) |
EE (1) | EE9800408A (en) |
GE (1) | GEP20012500B (en) |
IL (1) | IL126833A0 (en) |
NO (1) | NO985405L (en) |
NZ (1) | NZ332712A (en) |
PL (1) | PL330120A1 (en) |
SK (1) | SK161098A3 (en) |
WO (1) | WO1997044350A1 (en) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5968965A (en) * | 1996-01-30 | 1999-10-19 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6028201A (en) * | 1996-01-30 | 2000-02-22 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US5981562A (en) * | 1996-01-30 | 1999-11-09 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1997027854A1 (en) * | 1996-01-30 | 1997-08-07 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
WO1997027852A1 (en) * | 1996-01-30 | 1997-08-07 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
US6300501B1 (en) | 1996-05-22 | 2001-10-09 | Warner-Lambert Company | Histidine-(N-benzyl glycinamide) inhibitors of protein farnesyl transferase |
US6737410B1 (en) | 1997-04-11 | 2004-05-18 | Warner-Lambert Company | Inhibitors of protein farnesyl transferase |
WO1998046625A1 (en) * | 1997-04-11 | 1998-10-22 | Warner-Lambert Company | Dipeptide inhibitors of protein farnesyltransferase |
US20030069231A1 (en) | 1999-10-12 | 2003-04-10 | Klaus Rudolf | Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
JP2002513031A (en) | 1998-04-27 | 2002-05-08 | ワーナー−ランバート・カンパニー | Glycinamide derivatives with functionalized alkyl and alkenyl side chains as farnesyltransferase inhibitors |
WO2000034437A2 (en) | 1998-12-08 | 2000-06-15 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6316436B1 (en) | 1998-12-08 | 2001-11-13 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
WO2001051494A1 (en) | 2000-01-12 | 2001-07-19 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
JP2002188646A (en) * | 2000-12-20 | 2002-07-05 | Nsk Ltd | Rolling bearing and bearing device |
US7595312B2 (en) | 2002-10-25 | 2009-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
WO2005049589A2 (en) * | 2003-10-14 | 2005-06-02 | Cadila Healthcare Limited | Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases |
DE102004015723A1 (en) | 2004-03-29 | 2005-10-20 | Boehringer Ingelheim Pharma | Selected CGRP antagonists, process for their preparation and their use as pharmaceuticals |
ES2382814T3 (en) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Cis-4 - [(4-chlorophenyl) sulfonyl] -4- (2,5-difluorophenyl) cyclohexanopropanoic acid for cancer treatment |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
CA2770486C (en) | 2006-09-22 | 2014-07-15 | Merck Sharp & Dohme Corp. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
PL2109608T3 (en) | 2007-01-10 | 2011-08-31 | Msd Italia Srl | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
US8822497B2 (en) | 2007-03-01 | 2014-09-02 | Novartis Ag | PIM kinase inhibitors and methods of their use |
WO2008144062A1 (en) | 2007-05-21 | 2008-11-27 | Novartis Ag | Csf-1r inhibitors, compositions, and methods of use |
JP5501227B2 (en) | 2007-06-27 | 2014-05-21 | メルク・シャープ・アンド・ドーム・コーポレーション | 4-Carboxybenzylamino derivatives as histone deacetylase inhibitors |
WO2010114780A1 (en) | 2009-04-01 | 2010-10-07 | Merck Sharp & Dohme Corp. | Inhibitors of akt activity |
WO2010144909A1 (en) | 2009-06-12 | 2010-12-16 | Novartis Ag | Fused heterocyclic compounds and their uses |
US8859776B2 (en) | 2009-10-14 | 2014-10-14 | Merck Sharp & Dohme Corp. | Substituted piperidines that increase p53 activity and the uses thereof |
US9180127B2 (en) | 2009-12-29 | 2015-11-10 | Dana-Farber Cancer Institute, Inc. | Type II Raf kinase inhibitors |
AU2011227643A1 (en) | 2010-03-16 | 2012-09-20 | Dana-Farber Cancer Institute, Inc. | Indazole compounds and their uses |
EP2584903B1 (en) | 2010-06-24 | 2018-10-24 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
JP6043285B2 (en) | 2010-08-02 | 2016-12-14 | サーナ・セラピューティクス・インコーポレイテッドSirna Therapeutics,Inc. | RNA interference-mediated inhibition of catenin (cadherin-binding protein) β1 (CTNNB1) gene expression using small interfering nucleic acids (siNA) |
RU2624045C2 (en) | 2010-08-17 | 2017-06-30 | Сирна Терапьютикс,Инк | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
EP2613782B1 (en) | 2010-09-01 | 2016-11-02 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as erk inhibitors |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
EP2632472B1 (en) | 2010-10-29 | 2017-12-13 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina) |
WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
CN103732592A (en) | 2011-04-21 | 2014-04-16 | 默沙东公司 | Insulin-like growth factor-1 receptor inhibitors |
US9023865B2 (en) | 2011-10-27 | 2015-05-05 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
US9382239B2 (en) | 2011-11-17 | 2016-07-05 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-Jun-N-terminal kinase (JNK) |
US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
CA2882950A1 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
WO2014063068A1 (en) | 2012-10-18 | 2014-04-24 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
USRE48175E1 (en) | 2012-10-19 | 2020-08-25 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
RU2660349C2 (en) | 2012-11-28 | 2018-07-05 | Мерк Шарп И Доум Корп. | Compositions and methods for treatment of malignant tumour |
WO2014100065A1 (en) | 2012-12-20 | 2014-06-26 | Merck Sharp & Dohme Corp. | Substituted imidazopyridines as hdm2 inhibitors |
WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
EP3041938A1 (en) | 2013-09-03 | 2016-07-13 | Moderna Therapeutics, Inc. | Circular polynucleotides |
US10047070B2 (en) | 2013-10-18 | 2018-08-14 | Dana-Farber Cancer Institute, Inc. | Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7) |
EP3057955B1 (en) | 2013-10-18 | 2018-04-11 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of prolferative diseases |
US9862688B2 (en) | 2014-04-23 | 2018-01-09 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
WO2015164614A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
JO3589B1 (en) | 2014-08-06 | 2020-07-05 | Novartis Ag | Protein kinase c inhibitors and methods of their use |
AU2015371251B2 (en) | 2014-12-23 | 2020-06-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
WO2016160617A2 (en) | 2015-03-27 | 2016-10-06 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
EP3307728A4 (en) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | Combination therapy of transcription inhibitors and kinase inhibitors |
CA2996978A1 (en) | 2015-09-09 | 2017-03-16 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
JOP20190055A1 (en) | 2016-09-26 | 2019-03-24 | Merck Sharp & Dohme | Anti-cd27 antibodies |
EP3609922A2 (en) | 2017-04-13 | 2020-02-19 | Aduro Biotech Holdings, Europe B.V. | Anti-sirp alpha antibodies |
EP3706742B1 (en) | 2017-11-08 | 2023-03-15 | Merck Sharp & Dohme LLC | Prmt5 inhibitors |
WO2019148412A1 (en) | 2018-02-01 | 2019-08-08 | Merck Sharp & Dohme Corp. | Anti-pd-1/lag3 bispecific antibodies |
WO2020033282A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
US20210309688A1 (en) | 2018-08-07 | 2021-10-07 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5352705A (en) * | 1992-06-26 | 1994-10-04 | Merck & Co., Inc. | Inhibitors of farnesyl protein transferase |
CA2172125A1 (en) * | 1993-09-30 | 1995-04-06 | S. Jane Desolms | Inhibitors of farnesyl-protein transferase |
CA2170766A1 (en) * | 1993-11-05 | 1995-05-11 | Gary Louis Bolton | Substituted di- and tripeptide inhibitors of protein:farnesyl transferase |
US5571792A (en) * | 1994-06-30 | 1996-11-05 | Warner-Lambert Company | Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase |
-
1997
- 1997-04-29 GE GEAP19974612A patent/GEP20012500B/en unknown
- 1997-04-29 CZ CZ983764A patent/CZ376498A3/en unknown
- 1997-04-29 EE EE9800408A patent/EE9800408A/en unknown
- 1997-04-29 BR BR9709354A patent/BR9709354A/en not_active Application Discontinuation
- 1997-04-29 WO PCT/US1997/006591 patent/WO1997044350A1/en not_active Application Discontinuation
- 1997-04-29 EA EA199801031A patent/EA199801031A1/en unknown
- 1997-04-29 NZ NZ332712A patent/NZ332712A/en unknown
- 1997-04-29 SK SK1610-98A patent/SK161098A3/en unknown
- 1997-04-29 IL IL12683397A patent/IL126833A0/en unknown
- 1997-04-29 JP JP09542369A patent/JP2000511527A/en not_active Abandoned
- 1997-04-29 CN CN97194835A patent/CN1219174A/en active Pending
- 1997-04-29 PL PL97330120A patent/PL330120A1/en unknown
- 1997-04-29 EP EP97922365A patent/EP0938494A1/en not_active Withdrawn
- 1997-04-29 AU AU28058/97A patent/AU728477B2/en not_active Ceased
- 1997-04-29 CA CA002253934A patent/CA2253934A1/en not_active Abandoned
- 1997-05-26 CO CO97028769A patent/CO4960642A1/en unknown
-
1998
- 1998-11-19 BG BG102936A patent/BG102936A/en unknown
- 1998-11-20 NO NO985405A patent/NO985405L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1997044350A1 (en) | 1997-11-27 |
CN1219174A (en) | 1999-06-09 |
JP2000511527A (en) | 2000-09-05 |
SK161098A3 (en) | 2000-06-12 |
GEP20012500B (en) | 2001-07-25 |
CA2253934A1 (en) | 1997-11-27 |
EE9800408A (en) | 1999-06-15 |
CZ376498A3 (en) | 1999-02-17 |
EP0938494A1 (en) | 1999-09-01 |
PL330120A1 (en) | 1999-04-26 |
AU2805897A (en) | 1997-12-09 |
IL126833A0 (en) | 1999-08-17 |
BR9709354A (en) | 1999-08-10 |
EA199801031A1 (en) | 1999-06-24 |
NO985405L (en) | 1999-01-19 |
CO4960642A1 (en) | 2000-09-25 |
NO985405D0 (en) | 1998-11-20 |
AU728477B2 (en) | 2001-01-11 |
BG102936A (en) | 1999-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ332712A (en) | Polypeptide inhibitors of protein farnesyl transferase | |
TW369617B (en) | Plastic articles for medical use | |
FI935673A0 (en) | Amino-substituted pyrazoler | |
GR20010300028T1 (en) | Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis | |
NO972198L (en) | 6-Aryl-pyrido 2,3-d] pyrimidines and naphthyridines for inhibition of protein-tyrosine kinase-induced rapid cell growth | |
ATE226226T1 (en) | ORGANOSILANE OLIGOMERS | |
PL326159A1 (en) | Heterocyclic fungicides | |
EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
MY126779A (en) | Benzoylcyclohexanediones, process for their preparation and their use as herbicides and plant growth regulators | |
DE69420560T2 (en) | MODIFIED SILOXANE-POLYOLEFIN COPOLYMERS | |
ATE174600T1 (en) | 2'-AMIDO AND 2'-PEPTIDO-MODIFIED OLIGONUCLEOTIDES | |
CA2256582A1 (en) | Oxa acids and related compounds for treating skin conditions | |
HU9601342D0 (en) | Fungicidal cyclic amides | |
MX9704736A (en) | Substituted azetidin-2-ones for treatment of atherosclerosis. | |
TR199901653T2 (en) | Phthalazinones. | |
WO1991019707A3 (en) | Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones | |
MX9708621A (en) | 'beta'-ADRENERGIC AGONISTS. | |
DK1149092T3 (en) | 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles | |
PT97746A (en) | PROCESS OF ENANTIO-SELECTIVE PREPARATION OF PHENYL-ISO-SERIN DERIVATIVES | |
AU570920B2 (en) | 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines | |
NO20000853D0 (en) | Polysiloxane-based block copolymers and process for their preparation | |
MX9708452A (en) | Inhibitors of bacterial sialidase and methods of making and using the same. | |
TR199701202T1 (en) | New hydroxymic acid derivatives. | |
DE69026954T2 (en) | CONTINUOUS CELL CULTURE SYSTEM OF HIGH TIGHTNESS | |
NO983283L (en) | Hydrocamic acid-based collagenase inhibitors |